PHAXIAM Therapeutics Competitors and Similar CompaniesClear all

PHAXIAM Therapeutics's competitors and similar companies include Polymun and Aeglea.

	PHAXIAM Therapeutics PHAXIAM Therapeutics (formerly known as Erytech Pharma) is a biopharmaceutical company that develops enzyme-based medicinal products for the oncology, hematology, and immunology sectors.	Polymun Polymun is a company specializing in contract development and manufacturing as well as creating liposomal formats of drugs for contract partners.	Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
Founding Date	Founding Date 2004	Founding Date 1992	Founding Date 2013
Type	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech contractor drug development pharma	Tags Healthcare biotech drug development oncology
Locations	Locations Lyon, FR HQ Cambridge, US Princeton, US	Locations Klosterneuburg, AT HQ	Locations Austin, US HQ
Employees	Employees 49	Employees 80	Employees 65117% increase
Valuation ($)	Valuation ($) 52.8 m	Valuation ($) N/A	Valuation ($) 48.6 m
Financial
Net income	Net income (€23.5m) (FY, 2023)	Net income N/A	Net income ($155.2m) (FY, 2025)

For sources of this data, please see the company profile

Klosterneuburg, AT

Employees

Polymun is a company specializing in contract development and manufacturing as well as creating liposomal formats of drugs for contract partners.

Austin, US

Employees

Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.

Financial